Income Taxes (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Dec. 31, 2017 |
|
Income tax examination | Changes include, but are not limited to, a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017 | ||||
Federal corporate tax rate | 21.00% | ||||
Income tax (benefit) expense | $ (1,342) | $ 71 | $ (1,272) | $ 218 | |
Effective income tax rate reconciliation, percent | 130.90% | 3.70% | 1479.10% | 6.00% | |
Tax Cuts and Jobs Act [Member] | |||||
Income tax (benefit) expense | $ 1,380 | $ 1,695 | |||
Percentage of NOL uitilized | 80.00% | 80.00% | |||
Indefinite-lived deferred tax liabilities percentage | 80.00% | 80.00% | |||
Valuation allowance percentage against deferred tax assets | 80.00% |
X | ||||||||||
- Definition Deferred tax assets related to indefinite-lived NOLs may now be used to offset indefinite-lived deferred tax liabilities, No definition available.
|
X | ||||||||||
- Definition NOLs to taxable income in the year in which the NOL is utilized. No definition available.
|
X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|